Protein Kinase STK24 Promotes Tumor Immune Evasion via the AKT‐PD‐L1 Axis

Abstract Immunotherapy targeting PD‐L1 is still ineffective for a wide variety of tumors with high unpredictability. Deploying combined immunotherapy with alternative targeting is practical to overcome this therapeutic resistance. Here, the deficiency of serine‐threonine kinase STK24 is observed in...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ning Wang, Yu Jiang, Mengjie Li, Haofei Wang, Jie Pan, Yang Tang, Shaofang Xie, Yunyang Xu, Xu Li, Xuefei Zhou, Pinglong Xu, Wenlong Lin, Xiaojian Wang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2024-03-01
Edice:	Advanced Science
Témata:	AKT programmed cell death ligand 1 (PD‐L1) serine/threonine protein kinase 24 (STK24) tumor immune evasion
On-line přístup:	https://doi.org/10.1002/advs.202304342
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!